News & Events

 
Amend Surgical Signs Agreement With UFRF for Biomimetic Bone

Apr 06th 2017

Amend Surgical Signs Agreement With UFRF for Biomimetic Bone

Amend Surgical, Inc. (Amend), a medical device company focused on enhancing the regenerative capacity of bone replacement products, announced today an exclusive agreement with The University of Florida Research Foundation (UFRF) to license patents for the development of Biomimetic Bone, a novel artificial bone substitute.

READ MORE
Amend Surgical Granted Rights to NanoFUSE

Apr 15th 2016

Amend Surgical Granted Rights to NanoFUSE

Nanotherapeutics, Inc., an integrated biopharmaceutical company with a focus on advanced development and manufacturing, today announced that the Company has granted an exclusive worldwide license to its proprietary bone void filler product, NanoFUSE® DBM (demineralized bone matrix), to Alachua, FL-based Amend Surgical, Inc.

READ MORE